MIRA INFORM REPORT

 

 

Report No. :

352597

Report Date :

03.12.2015

 

IDENTIFICATION DETAILS

 

Name :

DATWYLER PHARMA PACKAGING INDIA PRIVATE LIMITED

 

 

Formerly Known As :

HELVOET PHARMA INDIA OPERATIONS PRIVATE LIMITED

 

 

Registered Office :

Plot No. 5, Khandala, Sez MIDC, Village Kesurdi, District Satara – 412801, Maharashtra

Tel. No.:

91-2162-398239

 

 

Country :

India

 

 

Financials (as on) :

31.03.2015

 

 

Date of Incorporation :

05.12.2009

 

 

Com. Reg. No.:

11-144482

 

 

Capital Investment / Paid-up Capital :

RS. 656.234 Million

 

 

CIN No.:

[Company Identification No.]

U25203PN2009PTC144482

 

 

IEC No.:

Not Divulged

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

Not Available

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

The company is engaged in business of pharma packaging. (Registered Activity)

 

 

No. of Employees :

Information declined by the management 

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (45)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is a subsidiary of “Daetwyler Pharma Pack Holding AG” Argentina. It is established company having satisfactory track record.

 

The rating on company reflects significant improvement into its operational risk profile, healthy profit from its operations during FY-14, due to profit the company has been able to wipe-off some part of its accumulated losses.

 

The Rating further takes into account on company’s strong financial, managerial support and equity infusion from its holding company during the year under review.

 

Trade relations are fair. Business is active. Payments are reported to be usually correct.

 

In view of strong holding company support, the company can be considered normal for business dealings at usual trade terms and conditions.

 

Note:-

As per registrar of companies the date of balance sheet (i.e. financial filed) is show as 31.03.2015 but the documents related to the financials are not been available from any sources.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2015.

 

 

INFORMATION DENIED BY

 

Name :

Pandurang

Designation :

Manager

Contact No.:

91-8308805877

Date :

02.12.2015

 

 

LOCATIONS

 

Registered Office :

Plot No. 5, Khandala, Sez MIDC, Village Kesurdi, District Satara – 412801, Maharashtra, India

Tel. No.:

91-2162-398239

Fax No.:

Not Available

E-Mail :

Pharma@datwyler.com

devendra.mishra@datwyler.com

Website :

http://www.datwyler.com

 


 

 

DIRECTORS

 

AS ON 17.09.2014

 

Name :

Dirk Leonardus M Borghs

Designation :

Director

Address :

Acacialaan 37 2460 Kasterlee, NA, Belgium

Date of Birth/Age :

03.11.1963

Date of Appointment :

03.04.2010

DIN No.:

02919667

 

 

Name :

Willy Belmans

Designation :

Director

Address :

Eikenboomlaan 20, 2450 Meerhout, Meerhout, Na, Belgium

Date of Birth/Age :

22.02.1958

Date of Appointment :

03.04.2010

DIN No.:

02919687

 

 

Name :

Rahul Devaprasad Dev

Designation :

Director

Address :

Rose Parade Kondhawa KD, BL- C4, Near- Sai Dwarkamai SOC, Pune-411048, Maharashtra, India

Date of Birth/Age :

15.02.1969

Date of Appointment :

15.10.2012

DIN No.:

06400766

 

 

Name :

Dirk Lambrecht

Designation :

Additional director

Address :

Aeschrain 2B, 6318 Walchwil, Switzerland, 6318, , Switzerland

Date of Birth/Age :

12.12.1960

Date of Appointment :

15.01.2014

DIN No.:

06752969

 

 

Name :

Rolf Kronenberg

Designation :

Additional director

Address :

Schutzenstrasse 52,, 6430 Schwyz, Reiden LU, 6430, , Switzerland

Date of Birth/Age :

20.12.1960

Date of Appointment :

15.01.2014

DIN No.:

06752979

 

 

Name :

Holger Oertel

Designation :

Director

Address :

Koehlerweg 8, Adendorf, 21365, Germany

Date of Appointment :

24.09.2015

DIN No.:

02202570

 

 

KEY EXECUTIVES

 

Name :

Pandurang

Designation :

Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 17.09.2014

 

Names of Shareholders

 

No. of Shares

Matrijzenmakerji ‘MARO’ BV

 

22150683

Helvoet Pharma Belgium NV

 

2162

Daetwyler Pharma Pack Holding AG, Switzerland

 

43470508

 

 

 

Total

 

65623353

 

Equity Share Break up (Percentage of Total Equity)

 

AS ON 17.09.2014

 

Category

Percentage

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

100.00

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

The company is engaged in business of pharma packaging. (Registered Activity)

 

 

Products :

Item Code No.

Product Description

70109000

Pharma Packaging

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

Not Divulged

 

PRODUCTION STATUS: NOT AVAILABLE

 


 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

Customers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

No. of Employees :

Information declined by the management 

 

 

Bankers :

BNP Paribas, 20, Collyer Quay,, #01-01 Tung Centre,, Singapore - 049319, Singapore

 

 

Facilities :

(Rs. In Million)

 

SECURED LOAN

As on

31.03.2014

As on

31.03.2013

LONG TERM BORROWING

 

 

Rupee term loans from banks

113.225

411.950

 

 

 

Total

113.225

411.950

 

Auditors :

 

Name :

S R B C and Company LLP

Chartered Accountants

Address :

Yerwada Pune

PAN No.:

ACHFS9117R

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Fellow Subsidiary Company :

  • Datwyler Pharma Packaging Belgium NV
  • Datwyler Pharma Packaging Italy Srl
  • Datwyler Pharma Packaging USA Inc
  • Datwyler Pharma Packaging International NV
  • Datwyler IT Services AG
  • Daetwyler Pharma Pack Holding AG

 

 

CAPITAL STRUCTURE

 

AS ON 17.09.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

71,000,000

Equity Shares

Rs.10/- each

Rs.710.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

65,623,353

Equity Shares

Rs.10/- each

Rs.656.234 Millions

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2015

31.03.2014

31.03.2013

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

656.234

550.590

550.590

(b) Reserves & Surplus

(262.651)

(612.331)

(248.820)

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

156.352

0.000

Total Shareholders’ Funds (1) + (2)

393.583

94.611

301.770

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

1273.589

1252.430

980.230

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

8.315

0.000

0.000

Total Non-current Liabilities (3)

1281.904

1252.430

980.230

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

381.961

262.865

16.853

(b) Trade payables

364.175

98.867

74.511

(c) Other current liabilities

319.728

313.344

169.936

(d) Short-term provisions

1.050

3.525

0.577

Total Current Liabilities (4)

1066.914

678.601

261.877

 

 

 

 

TOTAL

2742.401

2025.642

1543.877

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

1471.927

1434.680

1316.112

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

351.100

60.458

71.868

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

118.571

91.149

18.050

(e) Other Non-current assets

2.000

1.500

0.000

Total Non-Current Assets

1943.598

1587.787

1406.030

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

386.451

235.002

88.238

(c) Trade receivables

271.724

159.052

13.516

(d) Cash and cash equivalents

110.787

35.492

32.961

(e) Short-term loans and advances

29.841

8.309

3.132

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

798.803

437.855

137.847

 

 

 

 

TOTAL

2742.401

2025.642

1543.877

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2015

 

31.03.2014

31.03.2013

 

SALES

 

 

 

 

Income

1654.786

663.587

14.442

 

Other Income

156.457

0.091

7.707

 

TOTAL                                    

1811.243

663.678

22.149

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Other expenses

1326.818

900.157

 

 

TOTAL                                    

1326.818

900.157

228.622

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

484.425

(236.479)

Including

 

 

 

 

Financial

Less

FINANCIAL EXPENSES                                   

148.885

127.031

And

 

 

 

 

Depreciation

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION

335.540

(363.510)

Expenses

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

36.915

0.000

 

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX

298.625

(363.510)

(206.473)

 

 

 

 

 

Less

TAX                                                                 

0.000

0.000

42.347

 

 

 

 

 

 

PROFIT/ (LOSS) AFTER TAX

298.625

(363.510)

(248.820)

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

Export Earnings

NA

638.887

13.434

 

TOTAL EARNINGS

NA

638.887

13.434

 

 

 

 

 

 

Earnings Per Share (Rs.)

4.55

 6.60

 --

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2015

31.03.2014

31.03.2013

Current Maturities of Long term debt

NA

274.633

116.050

Cash generated from operations

NA

NA

NA

Net cash flows from (used in) operations

NA

NA

NA

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2015

31.03.2014

31.03.2013

Net Profit Margin

(PAT / Sales)

(%)

18.05

(54.78)

(1722.89)

 

 

 

 

 

 

Operating Profit Margin

(PBIDT/Sales)

(%)

29.27

(35.64)

0.00

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

12.49

(18.50)

(14.03)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.76

(3.84)

(0.68)

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

4.21

16.02

3.30

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.75

0.65

0.53

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

550.590

550.590

656.234

Reserves & Surplus

(248.820)

(612.331)

(262.651)

Share Application money pending allotment

0.000

156.352

0.000

Net worth

301.770

94.611

393.583

 

 

 

 

long-term borrowings

980.230

1252.430

1273.589

Short term borrowings

16.853

262.865

381.961

Current Maturities of Long Term Debt

0.000

0.000

0.000

Total borrowings

997.083

1515.295

1655.550

Debt/Equity ratio

3.304

16.016

4.206

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

14.442

663.587

1654.786

 

 

4,494.841

149.370

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2013

31.03.2014

31.03.2015

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

14.442

663.587

1654.786

Profit/ (Loss)

(248.820)

(363.510)

298.625

 

(1722.89%)

(54.78%)

18.05%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

No

8

Designation of contact person

No

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

No

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

NOTE: Registered office of the company has been shifted from A-10, Green  Park, New Delhi – 110016, India to the present address w.e.f. 24.07.2012.

 

 

UNSECURED LOAN

 

(Rs. In Million)

Particulars

As on

31.03.2014

As on

31.03.2013

LONG TERM BORROWING

 

 

Rupee term loans from banks

1160.364

840.480

SHORT TERM BORROWING

 

 

Working capital loans from banks

381.961

262.865

Total

1542.325

1103.345

 

 

 

 

 

INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10352807

03/08/2012 *

663,800,000.00

BNP PARIBAS

20, Collyer Quay,, #01-01 Tung Centre,, Singapore 
, - 049319, SINGAPORE

B57408122

 

* Date of charge modification

 

 

FIXED ASSETS

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

Indian Rupees

US Dollar

1

Rs. 66.62

UK Pound

1

Rs. 100.34

Euro

1

Rs. 70.67

 

 

INFORMATION DETAILS

 

Information Gathered by :

SVA

 

 

Analysis Done by :

KAS

 

 

Report Prepared by :

JYO

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILITY

1~10

6

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

--

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

45

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.